……

He was not at all surprised by this result.

After all, this medicine was formulated by the system, so how could there be any problems?

Even if there is a problem, it can only occur in the production process, and it is impossible that there is a problem with the formula. This can be absolutely guaranteed.

The reason why he conducted the simulation was just to provide an extra layer of security, and he did not doubt the formula itself.

The most important thing is that Chen Xuan can now conduct simulations to come up with the best treatment method.

At that time, he can carry out targeted treatment in clinical trials, thus saving a lot of trial time.

This alone is worth his special simulation.

"After all drugs are officially produced,"

“You can also randomly select some drugs from each batch for analysis.”

"If there are problems in the production process, they can be discovered immediately and will not flow into the market."

Looking at humans and medical simulators, Chen Xuan thought of another very important link.

The drug production process is very important. Once a problem occurs, the consequences will be unimaginable.

Problems in drug production are much more serious than those in food production. No one knows whether problems with the ingredients of a drug will turn it from a cure into a deadly poison.

For example, the generic drugs produced by Dasheng Pharmaceutical Group become poisons because of problems with their ingredients.

It is very likely that general inspection methods will not be able to analyze this problem, so it is easy for the product to flow directly from production to the market, and finally be taken by patients, where the problem is discovered.

The consequences will be very serious and the losses will be staggeringly large.

But with human and medical simulators,

Chen Xuan can avoid this problem.

As long as every drug and every batch is randomly inspected, this uncertainty can be minimized or even completely eliminated.

In this way, the most important problem was solved at once.

For this human and medical simulator,

Chen Xuan was becoming more and more satisfied.

Sure enough, the points he had accumulated for so long were not wasted.

At the same time, she was amazed by the system's magical powers, and she wanted to discover more undiscovered wonders.

Next,

When humans and medical simulators are simulated,

Chen Xuan started doing drug experiments again, this time with more motivation.

Because his new drug trials can be simulated directly by this device in the future, he can know the results of such experiments at the first time.

At the same time, he can also continuously improve the experiments and adjust the formula based on the results given by the equipment, and finally he may be able to develop real results.

By then, maybe he won't even need the system to provide a formula to develop new drugs.

And this possibility made him even more impatient.

It also makes him more motivated when conducting drug experiments now.

……

"Antai Pharmaceutical Group borrowed 400 billion yuan from the bank?"

"This 400 billion yuan is an interest-free loan provided by four banks specifically for Antai Pharmaceutical Group?"

After receiving the news, Anna was completely shocked.

But at the same time, she couldn't help but feel disappointed that her original plan had failed again.

Originally, she planned to take advantage of the time when Chen Xuan was most in need of money to raise funds and invest in order to obtain a portion of the new drug shares.

After all, when multiple new drugs are undergoing clinical trials at the same time, funding will definitely be tight, and this is the best opportunity for financing.

However, she did not expect that China's four major banks would offer interest-free loans totaling 400 billion yuan, which made her plan fall through.

With the 400 billion yuan interest-free loan, Antai Pharmaceutical Group will basically never be short of money.

400 billion yuan is enough to complete the entire clinical trial. Before the money is used up, the new drug will definitely be launched on the market and profitable.

So Chen Xuan will definitely not be short of money.

"The big four banks don't do this for no reason."

"The 400 billion interest-free loan must have been ordered by Hua Xia."

"But this isn't surprising. Antai Pharmaceutical Group is so dazzling that China will definitely support it."

Anna also quickly thought of this.

Banking is an industry that only does business if there is profit.

How could a bank possibly touch such a thing that has no profit?

Unless it is a task assigned by Hua Xia himself, it is possible that the bank will not even take the benefits.

After all, the four major banks are state-owned banks, which are different from private banks. They must follow the instructions of the state.

"It seems that China is also expressing its attitude by doing this."

"We want outside investors to know that Antai Pharmaceutical Group is not something they can get involved in."

"Therefore, we at Novartis basically have no hope of raising funds. At best, we can only cooperate, and as for other capital, it is even more impossible."

After sorting out everything, Anna looked regretful.

It seemed as if a large number of opportunities had slipped away from her.

“Pfizer was shorted this time.”

"I wonder if it has anything to do with Chen Xuan?"

"I heard that the short position this time exceeded 20 billion US dollars. Could it be his handiwork?"

Anna also thought about this again.

She asked someone to keep an eye on Pfizer's movements, hoping to do a favor for Chen Xuan.

As a result, we didn't hear any news from Pfizer, but instead discovered that Pfizer was being shorted.

Pfizer has been shorted on a large scale, with the current short position exceeding US$200 billion, making it the largest short position at present.

Short selling at the tens of billions level is still very rare. It usually only occurs in giants such as fruit companies and Tesla. It is relatively rare for pharmaceutical companies to be shorted on such a large scale.

In particular, Pfizer's market value is only about 200 billion US dollars, and the short position has now reached 20 billion US dollars, which is equivalent to 1/10 of its market value.

Even giants like Apple and Tesla, which are often shorted, have never experienced this situation.

That's why Anna was very surprised.

This news also caused turmoil in the entire financial market. They all wanted to know who was short selling.

It is naturally impossible for a $200 billion short sale to come from one person, but everyone knows that the bulk of it must come from one person or one company.

As for who this person is and why he shorted Pfizer, that is a mystery.

For Anna, the first person she thought of was Chen Xuan.

Although, she didn't know why she thought of him, she just felt that he was the most likely one.

"I remember him shorting his opponent before."

"It seems to be the Dasheng Pharmaceutical Group. He seemed to have made hundreds of billions, but this group also went bankrupt."

"If the company being shorted this time is Pfizer, what kind of trump card has he prepared? Will Pfizer also be doomed like Dasheng Pharmaceutical Group?"

Anna suddenly remembered the past.

She still has a vivid memory of the short selling of Dasheng Pharmaceutical Group.

This move is exactly the same as the previous short-selling of Dasheng Pharmaceutical Group, so she thought of Chen Xuan first.

And now, she is also very much looking forward to his trump card.

She would naturally be happy if it could bring bad luck to Pfizer.

Pfizer is also a competitor of Novartis.

The more unlucky the opponent is, the greater the profit will be.

But An Yi was more looking forward to Chen Xuan's move. She really wanted to know what killer move he had prepared to short Pfizer.

……

Tap the screen to use advanced tools Tip: You can use left and right keyboard keys to browse between chapters.

You'll Also Like